Imugene Limited (ASX:IMU) Three Complete Responses in Azer-Cel Phase 1b Trial

(3:51)

Imugene’s $20 million boost and cancer trial updates

(7:42)

Imugene will present lead candidate HER-Vaxx at AACR Annual Meeting

(2:16)

Imugene's CEO interviewed on ausbiz detailing a clinical trial deal with Merck Germany and Pfizer.

(4:12)

How Imugene is Turning Viruses into Cancer-Fighting Heroes!

(32:27)

Baby shower part1 \u0026 part2 | 2022

(6:29)

Interview With The CF33 Oncolytic Virus Inventor - Imugene (IMU)

(20:11)

Imugene expands CAR T-Cell and Oncolytic Virotherapy trials in Australia and the US

(5:25)

Groundbreaking cancer trial: Imugene’s CF33 advances in clinical success

(16:2)

Leslie Chong Discusses Imugene's Strategic Partnership with Kincell Bio | AusBiz Interview

(6:37)

Imugene's Founder and Executive Chairman's keynote speech at Emerging Small Caps Summit 2021

(19:6)

Deploy LLM to AWS Sagemaker | iNeuron

(1:44:52)

Imugene Investor Presentation | Non-deal Roadshow 2023 Australia

(44:28)

Imugene Investor Webinar with special guests Bradley Glover and Paul Woodard

(39:40)

Imugene's CEO Leslie Chong presents at the 2023 JP Morgan Healthcare Conference in San Francisco.

(16:42)

Imugene (ASX:IMU) | Webinar with Leslie Chong | 07/11/24

(26:56)

Imugene forges development path of immunotherapies and cancer-killing virus

(24:2)

Imugene expands CAR T-Cell and Oncolytic Virotherapy trials in Australia and the US

(5:25)

Imugene: A worldwide license to attack blood cancer

(2:59)

Imugene CEO hails clinical milestone for HER-Vaxx cancer immunotherapy

(6:15)

Imugene talks ABL partnership for VAXINIA and $80 million institutional capital raise

(4:50)

Imugene @ AACR 2020: VAXinia (CF33-hNIS) Phase 1 Briefing

(4:43)

Imugene partners with Kincell Bio; selling cell therapy manufacturing facility for $6 million

(5:34)

Imugene: Serious inroads – a highly successful cancer drug trial

(3:7)

Imugene opens enrolment for Bile Tract Cancer expansion study

(5:2)

Groundbreaking cancer trial: Imugene’s CF33 advances in clinical success

(16:2)

Changing the lives of cancer patients | Dr Leslie Chong of Imugene | ASX CEO Connect Series

(29:22)